About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.
2018 Juristant Badge - MBHB_165
Juristat #4 Overall Rank

E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.

Contact the Docs

Docs on Twitter


Disclaimer

  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat_165
Juristat #8 Overall Rank

Pharma-50-transparent_216px_red

« Docs at BIO: Panel Offers Suggestions for Fixing the USPTO -- Updated | Main | GSK's Sherry Knowles Responds to Post on BIO Session »

May 21, 2009

Comments

Last week, the U.S. District Court for the Northern District of Illinois ruled that KGK Synergize Inc. could not avoid a determination of validity and infringement on the basis that the co-owner of the patent-in-suit is the United States government.


Quote: KGK in fact welcomes the opportunity of a full Jury trial in order to vindicate its position and patent rights.Far too often infringement cases are settled in secretive agreements that do not fully expose the infringing party.

The comments to this entry are closed.

September 2023

Sun Mon Tue Wed Thu Fri Sat
          1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30